Who we are and what we do?

Arthritis Innovation Corporation (AIC) is a biotechnology company focused on the development of novel therapies for diseases and conditions associated with arthritis.

A private company founded in 2013 by orthopedic surgeons Dr. Nizar Mahomed and Dr. Wayne Marshall of the Toronto Western Hospital, AIC is a joint venture with the biotechnology company, MedinCell (www.medincell.com) of Montpellier, France.

Leveraging an experienced world-class product development team in Toronto, Canada with MedinCell's proprietary polymer platform technology, AIC is developing specific applications of the injectable technology to address unmet needs in orthopedics.